The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Triclabendazole: new skills to unravel an old(ish) enigma
Abstract
Triclabendazole was introduced in the early 1980s for the treatment of Fasciola hepatica infections in livestock. Due to its high activity against immature flukes, it has become established as the principal anti-fluke drug on the market. More recently, triclabendazole has been used to treat human cases of fascioliasis and is now the drug of choice for this infection, too. Resistance to triclabendazole was first reported in 1995 in a field population in Australia and, since that time, resistant populations have been identified in several countries in Europe. Parallel to the spread of resistance has been a sharp increase in the prevalence of fascioliasis, which has been attributed largely to climate changes. Consequently, farmers are faced with an alarming scenario, as none of the other fasciolicides on the market possess such high activity against the damaging immature stages of fluke. The main aim of this review is to assess current understanding of the mechanism of action of triclabendazole against the fluke and the mechanism by which the fluke has become resistant to it. The use of triclabendazole against animal and human infections is summarized and suggestions are given on ways to deal with resistance. Gaps in the knowledge of various aspects of its use are highlighted and this may serve to open up future research areas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug resistance in veterinary helminths
Wolstenholme, A. J., Fairweather, I., Prichard, R., von Samson-Himmelstjerna, G., & Sangster, N. C. (2004) · Trends in Parasitology · doi:10.1016/j.pt.2004.07.010 · Cited by 813
Self-citationLacey, E. (1988) · International Journal for Parasitology · doi:10.1016/0020-7519(88)90175-0 · Cited by 560
Kwa, M. S. G., Veenstra, J. G., & Roos, M. H. (1994) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(94)90066-3 · Cited by 424
Robinson, M. W., Fairweather, I., Lawson, J., Trudgett, A., & Hoey, E. M. (2004) · Parasitology Research · doi:10.1007/s00436-003-1003-6 · Cited by 105
Self-citationHuman fascioliasis successfully treated with triclabendazole
Laird, P. P., & Boray, J. C. (1992) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1992.tb01708.x · Cited by 32
Cited by
Marshall, C. M., Federice, J. G., Bell, C. N., Cox, P. B., & Njardarson, J. T. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01122 · Cited by 1,064
Current Threat of Triclabendazole Resistance in Fasciola hepatica
Kelley, J. M., Elliott, T. P., Beddoe, T., Anderson, G., Skuce, P., & Spithill, T. W. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.03.002 · Cited by 319
Triclabendazole for the treatment of fascioliasis and paragonimiasis
Keiser, J., Engels, D., Büscher, G., & Utzinger, J. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.12.1513 · Cited by 211
Metadata
- Authors
- Fairweather, I.
- Venue
- Journal of Helminthology
- Publisher
- Cambridge University Press (CUP)
- Published
- 2005-09
- Volume
- 79
- Issue
- 3
- Pages
- 227-234
- ISSN
- 0022-149X (ISSN-L)
- 1475-2697
- OpenAlex
- W2134575926
- Cited by
- 199
- References
- 5
- FWCI
- 17.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Triclabendazole: new skills to unravel an old(ish) enigma. https://app.cochat.ai/papers/10.1079/joh2005298
- The paper
- Fairweather, I. (2005). Triclabendazole: new skills to unravel an old(ish) enigma. Journal of Helminthology. https://doi.org/10.1079/joh2005298
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.